Literature DB >> 27729581

Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease.

Aylin Tugcu1, Zhezhen Jin1, Shunichi Homma1, Mitchell S V Elkind1, Tatjana Rundek1, Mitsuhiro Yoshita1, Charles DeCarli1, Koki Nakanishi1, Sofia Shames1, Clinton B Wright1, Ralph L Sacco1, Marco R Di Tullio2.   

Abstract

BACKGROUND AND
PURPOSE: Aortic arch plaque (AAP) is a risk factor for ischemic stroke, but its association with subclinical cerebrovascular disease is not established. We investigated the association between AAP and subclinical cerebrovascular disease in an elderly stroke-free community-based cohort.
METHODS: The CABL study (Cardiovascular Abnormalities and Brain Lesions) was designed to investigate cardiovascular predictors of silent cerebrovascular disease in the elderly. AAPs were assessed by suprasternal transthoracic echocardiography in 954 participants. Silent brain infarcts and white matter hyperintensity volume (WMHV) were assessed by brain magnetic resonance imaging. The association of AAP thickness with silent brain infarcts and WMHV was evaluated by logistic regression analysis.
RESULTS: Mean age was 71.6±9.3 years; 63% were women. AAP was present in 658 (69%) subjects. Silent brain infarcts were detected in 138 participants (14.5%). In multivariate analysis adjusted for potential confounders, AAP thickness and large AAP (≥4 mm in thickness) were significantly associated with the upper quartile of WMHV (WMHV-Q4; odds ratio =1.17; 95% confidence interval, 1.04-1.32; P=0.009 and odds ratio =1.79; 95% confidence interval, 1.40-3.09; P=0.036, respectively), but not with silent brain infarcts (odds ratio =1.08; 95% confidence interval, 0.94-1.23; P=0.265 and odds ratio =1.46; 95% confidence interval, 0.77-2.77; P=0.251, respectively).
CONCLUSIONS: Aortic arch atherosclerosis was associated with WMHV in a stroke-free community-based elderly cohort. This association was stronger in subjects with large plaques and independent of cardiovascular risk factors. Aortic arch assessment by transthoracic echocardiography may help identify subjects at higher risk of subclinical cerebrovascular disease, who may benefit from aggressive stroke risk factors treatment.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; cerebrovascular diseases; silent brain infarct; stroke; white matter hyperintensity

Mesh:

Year:  2016        PMID: 27729581      PMCID: PMC5134895          DOI: 10.1161/STROKEAHA.116.015002

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  35 in total

Review 1.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

2.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

3.  Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

4.  Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.

Authors:  Clinton B Wright; Myunghee C Paik; Truman R Brown; Sally P Stabler; Robert H Allen; Ralph L Sacco; Charles DeCarli
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

5.  Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Authors:  Ralph L Sacco; Minesh Khatri; Tatjana Rundek; Qiang Xu; Hannah Gardener; Bernadette Boden-Albala; Marco R Di Tullio; Shunichi Homma; Mitchell S V Elkind; Myunghee C Paik
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

6.  Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Tom Den Heijer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

7.  Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease.

Authors:  Jonathan Y Streifler; Michael Eliasziw; Oscar R Benavente; Sonia Alamowitch; Allan J Fox; Vladimir Hachinski; Henry J M Barnett
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

8.  Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study.

Authors:  S Prabhakaran; C B Wright; M Yoshita; R Delapaz; T Brown; C DeCarli; R L Sacco
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

Review 9.  Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Authors:  Daniel E Jonas; Cynthia Feltner; Halle R Amick; Stacey Sheridan; Zhi-Jie Zheng; Daniel J Watford; Jamie L Carter; Cassandra J Rowe; Russell Harris
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

Review 10.  The proximal aorta: a source of stroke.

Authors:  E F Jones; G A Donnan
Journal:  Baillieres Clin Neurol       Date:  1995-08
View more
  3 in total

1.  Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study.

Authors:  Hugo J Aparicio; Rodica E Petrea; Joseph M Massaro; Warren J Manning; Noriko Oyama-Manabe; Alexa S Beiser; Carlos S Kase; Ralph B D'Agostino; Philip A Wolf; Ramachandran S Vasan; Charles DeCarli; Christopher J O'Donnell; Sudha Seshadri
Journal:  Atherosclerosis       Date:  2017-06-23       Impact factor: 5.162

2.  Ideal cardiovascular health and the subclinical impairments of cardiovascular diseases: a cross-sectional study in central south China.

Authors:  Ya-Qin Wang; Chang-Fa Wang; Ling Zhu; Hong Yuan; Liu-Xin Wu; Zhi-Heng Chen
Journal:  BMC Cardiovasc Disord       Date:  2017-10-18       Impact factor: 2.298

3.  Rosuvastatin protects against endothelial cell apoptosis in vitro and alleviates atherosclerosis in ApoE-/- mice by suppressing endoplasmic reticulum stress.

Authors:  Jianan Geng; Huali Xu; Wenwen Fu; Xiaofeng Yu; Guoliang Xu; Hongyan Cao; Guangzhu Lin; Dayun Sui
Journal:  Exp Ther Med       Date:  2020-05-08       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.